MS South Canterbury News

10 October 2014

The Multiple Sclerosis Society of New Zealand (MSNZ) is delighted by PHARMAC’s announcement that they will fund two new treatments for Multiple Sclerosis. Biogen Idec’s Natalizumab (trading as Tysabri) and Novartis’ Fingolimod (Gilenya) will be funded from 1 November 2014. PHARMAC has also approved increased access to currently-funded treatments in today’s announcement.

Read more ...

AllanHelp us give Alan some freedom by providing him with a specialist van. Alan is such an inspiring guy so if you can see your way to give-a-little to help him achieve is dream then Alan would be forever grateful to you. Please help Alan to achieve his one wish; a mobility vehicle. Alan was diagnosed with Multiple Sclerosis (MS) 20 years ago (1994) and over that time this disease, like rust, has slowly eroded his life and with it his dreams and aspirations. MS has slowly chipped away at Alan’s physical abilities; first his ability to walk and eventually his ability to stand. This took away his ability to transfer into and out of a conventional car and thus his ability to get out and about. Read on for his story…
Give-a-little-logoYOU CAN DONATE TO ALAN HERE:

Read more ...

Join us on Facebook


Back to top